September 5, 2025
RFK Jr. Blasts Pharma Industry and Spreads mRNA Vaccine Misinformation During Heated Senate Hearing
RFK Jr.; Senate hearing; pharma industry; mRNA misinformation; COVID-19 vaccines; public health; vaccine policy; CDC leadership
Recent Developments in Logistical Coordination for Decentralized Clinical Trials (DCTs)
Decentralized Clinical Trials; Logistics; FDA Guidance 2024; Remote Patient Monitoring; Supply Chain Management; Digital Trial Platforms
MRM Health Nets $64M and Treeline Gathers $200M: Fierce Biotech Fundraising Tracker 2025
MRM Health; Series B Funding; Microbiome therapeutics; Ulcerative colitis; Live Biotherapeutic Product (LBP); Biocodex; Treeline; Biotech fundraising; IBD therapy
Survival Benefit of Amgen’s Bemarituzumab in Gastric Cancer Attenuates at Final Analysis
Amgen; bemarituzumab; gastric cancer; Phase 3 trial; overall survival; attenuated benefit; final analysis; FORTITUDE-101; FORTITUDE-102; Zai Lab; Opdivo; nivolumab
FDA Pushes Back Agios’ Pyrukynd Thalassemia Decision to December
FDA; Agios; Pyrukynd; thalassemia; PDUFA; decision delay; REMS; hepatocellular injury
Atlas Venture Raises $400M Opportunity Fund to Bolster Biotech Portfolio
Atlas Venture; $400M growth fund; biotech startups; Opportunity Fund III; portfolio support; venture capital; late-stage funding; biopharma investment
FDA Releases Second Batch of Complete Response Letters, Moves to Real-Time Public Disclosure
FDA; Complete Response Letters; CRLs; real-time publishing; drug approvals; transparency; regulatory disclosure
Enveda Raises $150M Series D, Advances Nature-Inspired Drug Programs
Enveda Biosciences; Series D funding; $150 million; nature-inspired drug discovery; atopic dermatitis; immune diseases; Mikael Dolsten; biotech investment
RFK Jr. Faces Bipartisan Senate Criticism After CDC Shakeup
RFK Jr.; CDC shakeup; bipartisan criticism; Senate hearing; public health; vaccine policy; CDC director firing; Trump administration reforms